Kite Pharma Inc (KITE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -200,223 | -90,399 | -267,070 | -182,135 | -108,189 |
| Depreciation Amortization | 7,328 | 3,565 | 12,215 | 8,647 | 5,318 |
| Income taxes - deferred | 6,698 | N/A | -2,895 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,045 | 2,282 | 2,255 | 3,029 | -1,396 |
| Other Working Capital | 81,293 | 44,607 | 15,667 | 5,888 | 4,690 |
| Other Operating Activity | 50,175 | 22,138 | 70,924 | 49,578 | 33,794 |
| Operating Cash Flow | $-52,684 | $-17,807 | $-168,904 | $-114,993 | $-65,783 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -340,295 | 53,555 | -86,770 | -127,160 | -138,856 |
| PPE Investments | -5,595 | -2,374 | -20,146 | -17,025 | -13,784 |
| Purchase Of Investment | N/A | N/A | -6,025 | -6,025 | -6,025 |
| Investing Cash Flow | $-345,890 | $51,181 | $-112,941 | $-150,210 | $-158,665 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -87 | -44 | -126 | -90 | -57 |
| Common Stock Issued | 429,972 | 416,449 | 3,711 | 3,463 | 977 |
| Common Stock Repurchased | 1,776 | 780 | 2,369 | N/A | 841 |
| Other Financing Activity | 0 | 0 | -2,259 | -2,259 | 0 |
| Financing Cash Flow | $431,661 | $417,185 | $3,695 | $1,114 | $1,761 |
| Exchange Rate Effect | 188 | 33 | -132 | -4 | 2 |
| Beginning Cash Position | 114,561 | 114,561 | 392,843 | 392,843 | 392,843 |
| End Cash Position | 147,836 | 565,153 | 114,561 | 128,750 | 170,158 |
| Net Cash Flow | $33,275 | $450,592 | $-278,282 | $-264,093 | $-222,685 |
| Free Cash Flow | |||||
| Operating Cash Flow | -52,684 | -17,807 | -168,904 | -114,993 | -65,783 |
| Capital Expenditure | -5,595 | -2,374 | -20,146 | -17,025 | -13,784 |
| Free Cash Flow | -58,279 | -20,181 | -189,050 | -132,018 | -79,567 |